Cargando…
Clinical value of ALU concentration and integrity index for the early diagnosis of ovarian cancer: A retrospective cohort trial
CA125 amounts have a large overlap in ovarian cancer and benign diseases. We conducted a retrospective cohort trial to assess the clinical value of circulating cell-free DNA concentration and integrity index for the diagnosis of ovarian cancer. A total of 150 patients were recruited. Plasma samples...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798773/ https://www.ncbi.nlm.nih.gov/pubmed/29401471 http://dx.doi.org/10.1371/journal.pone.0191756 |
_version_ | 1783297897811410944 |
---|---|
author | Zhang, Rong PU, Wangyang Zhang, Shuyun Chen, Li Zhu, Weipei Xiao, Li Xing, Chungen Li, Kai |
author_facet | Zhang, Rong PU, Wangyang Zhang, Shuyun Chen, Li Zhu, Weipei Xiao, Li Xing, Chungen Li, Kai |
author_sort | Zhang, Rong |
collection | PubMed |
description | CA125 amounts have a large overlap in ovarian cancer and benign diseases. We conducted a retrospective cohort trial to assess the clinical value of circulating cell-free DNA concentration and integrity index for the diagnosis of ovarian cancer. A total of 150 patients were recruited. Plasma samples of 24 ovarian cancer patients, 12 benign ovarian cysts, and 12 healthy controls were assessed. By amplifying short ALU-115 repeat and long ALU-219 fragments, circulating cell-free DNA concentrations and integrity index were measured. Plasma ALU-219 fragment levels and integrity index were significantly higher in the ovarian cancer group compared with the benign disease and healthy control groups (p = 0.023 and p = 0.004, respectively). These findings indicated that plasma ALU-219 levels and integrity may have a clinical value in the early diagnosis of ovarian cancer. |
format | Online Article Text |
id | pubmed-5798773 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-57987732018-02-23 Clinical value of ALU concentration and integrity index for the early diagnosis of ovarian cancer: A retrospective cohort trial Zhang, Rong PU, Wangyang Zhang, Shuyun Chen, Li Zhu, Weipei Xiao, Li Xing, Chungen Li, Kai PLoS One Research Article CA125 amounts have a large overlap in ovarian cancer and benign diseases. We conducted a retrospective cohort trial to assess the clinical value of circulating cell-free DNA concentration and integrity index for the diagnosis of ovarian cancer. A total of 150 patients were recruited. Plasma samples of 24 ovarian cancer patients, 12 benign ovarian cysts, and 12 healthy controls were assessed. By amplifying short ALU-115 repeat and long ALU-219 fragments, circulating cell-free DNA concentrations and integrity index were measured. Plasma ALU-219 fragment levels and integrity index were significantly higher in the ovarian cancer group compared with the benign disease and healthy control groups (p = 0.023 and p = 0.004, respectively). These findings indicated that plasma ALU-219 levels and integrity may have a clinical value in the early diagnosis of ovarian cancer. Public Library of Science 2018-02-05 /pmc/articles/PMC5798773/ /pubmed/29401471 http://dx.doi.org/10.1371/journal.pone.0191756 Text en © 2018 Zhang et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Zhang, Rong PU, Wangyang Zhang, Shuyun Chen, Li Zhu, Weipei Xiao, Li Xing, Chungen Li, Kai Clinical value of ALU concentration and integrity index for the early diagnosis of ovarian cancer: A retrospective cohort trial |
title | Clinical value of ALU concentration and integrity index for the early diagnosis of ovarian cancer: A retrospective cohort trial |
title_full | Clinical value of ALU concentration and integrity index for the early diagnosis of ovarian cancer: A retrospective cohort trial |
title_fullStr | Clinical value of ALU concentration and integrity index for the early diagnosis of ovarian cancer: A retrospective cohort trial |
title_full_unstemmed | Clinical value of ALU concentration and integrity index for the early diagnosis of ovarian cancer: A retrospective cohort trial |
title_short | Clinical value of ALU concentration and integrity index for the early diagnosis of ovarian cancer: A retrospective cohort trial |
title_sort | clinical value of alu concentration and integrity index for the early diagnosis of ovarian cancer: a retrospective cohort trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798773/ https://www.ncbi.nlm.nih.gov/pubmed/29401471 http://dx.doi.org/10.1371/journal.pone.0191756 |
work_keys_str_mv | AT zhangrong clinicalvalueofaluconcentrationandintegrityindexfortheearlydiagnosisofovariancanceraretrospectivecohorttrial AT puwangyang clinicalvalueofaluconcentrationandintegrityindexfortheearlydiagnosisofovariancanceraretrospectivecohorttrial AT zhangshuyun clinicalvalueofaluconcentrationandintegrityindexfortheearlydiagnosisofovariancanceraretrospectivecohorttrial AT chenli clinicalvalueofaluconcentrationandintegrityindexfortheearlydiagnosisofovariancanceraretrospectivecohorttrial AT zhuweipei clinicalvalueofaluconcentrationandintegrityindexfortheearlydiagnosisofovariancanceraretrospectivecohorttrial AT xiaoli clinicalvalueofaluconcentrationandintegrityindexfortheearlydiagnosisofovariancanceraretrospectivecohorttrial AT xingchungen clinicalvalueofaluconcentrationandintegrityindexfortheearlydiagnosisofovariancanceraretrospectivecohorttrial AT likai clinicalvalueofaluconcentrationandintegrityindexfortheearlydiagnosisofovariancanceraretrospectivecohorttrial |